{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:35:11Z","timestamp":1772120111249,"version":"3.50.1"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100007443","name":"Friedrich Naumann Stiftung","doi-asserted-by":"publisher","award":["8683\/P611"],"award-info":[{"award-number":["8683\/P611"]}],"id":[{"id":"10.13039\/501100007443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007443","name":"Friedrich Naumann Stiftung","doi-asserted-by":"publisher","award":["2021"],"award-info":[{"award-number":["2021"]}],"id":[{"id":"10.13039\/501100007443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40120-022-00361-9","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T06:28:04Z","timestamp":1653114484000},"page":"931-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psychosocial Risk Factors for Alzheimer\u2019s Disease in Patients with Down Syndrome and Their Association with Brain Changes: A Narrative Review"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3273-7368","authenticated-orcid":false,"given":"Osama","family":"Hamadelseed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim H.","family":"Elkhidir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Skutella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"361_CR1","unstructured":"Akhtar F, Bokhari SRA. Down syndrome. Treasure Island: StatPearls; 2021."},{"key":"361_CR2","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541\u201354.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"361_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"key":"361_CR4","doi-asserted-by":"publisher","unstructured":"Holland A, Reinmuth O, editors. Aphasia or dementia: the cautionary tale of Dr. JJ. Seminars in speech and language. 1998. https:\/\/doi.org\/10.1055\/s-2008-1064034.","DOI":"10.1055\/s-2008-1064034"},{"issue":"2","key":"361_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1352\/0895-8017(2004)109<126:IAPODI>2.0.CO;2","volume":"109","author":"WB Zigman","year":"2004","unstructured":"Zigman WB, Schupf N, Devenny DA, et al. Incidence and prevalence of dementia in elderly adults with mental retardation without Down syndrome. Am J Ment Retard. 2004;109(2):126\u201341.","journal-title":"Am J Ment Retard"},{"issue":"2","key":"361_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S0033291700009120","volume":"16","author":"C Oliver","year":"1986","unstructured":"Oliver C, Holland A. Down\u2019s syndrome and Alzheimer\u2019s disease: a review. Psychol Med. 1986;16(2):307\u201322.","journal-title":"Psychol Med"},{"issue":"6","key":"361_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1192\/bjp.172.6.493","volume":"172","author":"AJ Holland","year":"1998","unstructured":"Holland AJ, Hon J, Huppert FA, Stevens F, Watson P. Population-based study of the prevalence and presentation of dementia in adults with Down\u2019s syndrome. Br J Psychiatry. 1998;172(6):493\u20138.","journal-title":"Br J Psychiatry"},{"key":"361_CR8","doi-asserted-by":"crossref","unstructured":"Salehi A, Wesson Ashford J, J Mufson E. Editorial (Thematic Issue: The Link between Alzheimer\u2019s Disease and Down Syndrome. A Historical Perspective). Curr Alzheimer Res. 2016;13(1):2\u20136.","DOI":"10.2174\/1567205012999151021102914"},{"issue":"29","key":"361_CR9","doi-asserted-by":"publisher","first-page":"12031","DOI":"10.1073\/pnas.0813248106","volume":"106","author":"JO Korbel","year":"2009","unstructured":"Korbel JO, Tirosh-Wagner T, Urban AE, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci. 2009;106(29):12031\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"361_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006;38(1):24\u20136.","journal-title":"Nat Genet"},{"key":"361_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1101\/SQB.1996.061.01.059","volume":"61","author":"DJ Selkoe","year":"1996","unstructured":"Selkoe DJ. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer\u2019s disease. Cold Spring Harb Symp Quant Biol. 1996;61:587\u201396.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"6","key":"361_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jalz.2011.09.229","volume":"8","author":"BL Handen","year":"2012","unstructured":"Handen BL, Cohen AD, Channamalappa U, et al. Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B. Alzheimers Dement. 2012;8(6):496\u2013501.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"361_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15(3):135\u201347.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"361_CR14","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1176\/appi.ajp.160.10.1870","volume":"160","author":"SJ Teipel","year":"2003","unstructured":"Teipel SJ, Schapiro MB, Alexander GE, et al. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down\u2019s syndrome. Am J Psychiatry. 2003;160(10):1870\u20138.","journal-title":"Am J Psychiatry"},{"key":"361_CR15","doi-asserted-by":"crossref","unstructured":"Aylward EH, Li Q, Honeycutt NA, et al. MRI volumes of the hippocampus and amygdala in adults with Down\u2019s syndrome with and without dementia. Am J Psychiatry. 1999;156(4):564-8","DOI":"10.1176\/ajp.156.4.564"},{"key":"361_CR16","doi-asserted-by":"crossref","unstructured":"Silva MVF, Loures CdMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MdG. Alzheimer's disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):33.","DOI":"10.1186\/s12929-019-0524-y"},{"key":"361_CR17","doi-asserted-by":"crossref","unstructured":"Kang S, Lee Y-h, Lee JE. Metabolism-centric overview of the pathogenesis of Alzheimer's disease. Yonsei Med J. 2017;58(3):479\u201388.","DOI":"10.3349\/ymj.2017.58.3.479"},{"key":"361_CR18","doi-asserted-by":"crossref","unstructured":"Ruthirakuhan M, Luedke AC, Tam A, Goel A, Kurji A, Garcia A. Use of physical and intellectual activities and socialization in the management of cognitive decline of aging and in dementia: a review. J Aging Res. 2012;2012:384875.","DOI":"10.1155\/2012\/384875"},{"issue":"2","key":"361_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111\u201328.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"361_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1866-1955-5-19","volume":"5","author":"D Mullins","year":"2013","unstructured":"Mullins D, Daly E, Simmons A, et al. Dementia in Down\u2019s syndrome: an MRI comparison with Alzheimer\u2019s disease in the general population. J Neurodev Disord. 2013;5(1):19.","journal-title":"J Neurodev Disord"},{"key":"361_CR21","doi-asserted-by":"crossref","unstructured":"Head E, Powell DK, Schmitt FA. Metabolic and vascular imaging biomarkers in Down syndrome provide unique insights into brain aging and Alzheimer disease pathogenesis. Front Aging Neurosci. 2018;10:191.","DOI":"10.3389\/fnagi.2018.00191"},{"issue":"10","key":"361_CR22","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1176\/appi.ajp.158.10.1659","volume":"158","author":"JD Pinter","year":"2001","unstructured":"Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL. Neuroanatomy of Down\u2019s syndrome: a high-resolution MRI study. Am J Psychiatry. 2001;158(10):1659\u201365.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"361_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13244-019-0729-3","volume":"10","author":"M Rodrigues","year":"2019","unstructured":"Rodrigues M, et al. Neuroimaging assessment in Down syndrome: a pictorial review. Insights Imaging. 2019;10(1):52. https:\/\/doi.org\/10.1186\/s13244-019-0729-3. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31111268.","journal-title":"Insights Imaging"},{"issue":"6\u20137","key":"361_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neurol.2011.11.007","volume":"168","author":"B Croisile","year":"2012","unstructured":"Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M. The new 2011 recommendations of the National Institute on Aging and the Alzheimer\u2019s Association on diagnostic guidelines for Alzheimer\u2019s disease: preclinal stages, mild cognitive impairment, and dementia. Rev Neurol (Paris). 2012;168(6\u20137):471\u201382.","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"361_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jaging.2013.03.002","volume":"27","author":"DPR Burnes","year":"2013","unstructured":"Burnes DPR, Burnette D. Broadening the etiological discourse on Alzheimer\u2019s disease to include trauma and posttraumatic stress disorder as psychosocial risk factors. J Aging Stud. 2013;27(3):218\u201324.","journal-title":"J Aging Stud"},{"issue":"5","key":"361_CR26","first-page":"335","volume":"79","author":"X Zhang","year":"1999","unstructured":"Zhang X, Li C, Zhang M. Psychosocial risk factors of Alzheimer\u2019s disease. Zhonghua Yi Xue Za Zhi. 1999;79(5):335\u20138.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"12","key":"361_CR27","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1080\/13607863.2017.1387760","volume":"22","author":"SL Burke","year":"2018","unstructured":"Burke SL, Cadet T, Alcide A, O\u2019Driscoll J, Maramaldi P. Psychosocial risk factors and Alzheimer\u2019s disease: the associative effect of depression, sleep disturbance, and anxiety. Aging Ment Health. 2018;22(12):1577\u201384.","journal-title":"Aging Ment Health"},{"issue":"5","key":"361_CR28","first-page":"153","volume":"49","author":"U Kropiunigg","year":"1999","unstructured":"Kropiunigg U, Sebek K, Leonhardsberger A, Schemper M, Dal-Bianco P. Psychosocial risk factors for Alzheimer\u2019s disease. Psychother Psychosom Med Psychol. 1999;49(5):153\u20139.","journal-title":"Psychother Psychosom Med Psychol"},{"issue":"1","key":"361_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/(SICI)1099-1166(199601)11:1<15::AID-GPS262>3.0.CO;2-5","volume":"11","author":"G Persson","year":"1996","unstructured":"Persson G, Skoog I. A prospective population study of psychosocial risk factors for late onset Dementia. Int J Geriatr Psychiatry. 1996;11(1):15\u201322.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"361_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ncl.2017.01.005","volume":"35","author":"MF Mendez","year":"2017","unstructured":"Mendez MF. Early-onset Alzheimer disease. Neurol Clin. 2017;35(2):263\u201381.","journal-title":"Neurol Clin"},{"issue":"2","key":"361_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jalz.2011.03.001","volume":"8","author":"H-X Wang","year":"2012","unstructured":"Wang H-X, Wahlberg M, Karp A, Winblad B, Fratiglioni L. Psychosocial stress at work is associated with increased dementia risk in late life. Alzheimers Dement. 2012;8(2):114\u201320.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"361_CR32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/oem.2003.012153","volume":"61","author":"A Seidler","year":"2004","unstructured":"Seidler A, Nienhaus A, Bernhardt T, Kauppinen T, Elo AL, Fr\u00f6lich L. Psychosocial work factors and dementia. Occup Environ Med. 2004;61(12):962.","journal-title":"Occup Environ Med"},{"key":"361_CR33","unstructured":"He YL, Zhang XK, Zhang MY. Psychosocial risk factors for Alzheimer's disease. Hong Kong J Psychiatry. 2000;10:2\u20137."},{"issue":"6","key":"361_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/s-2002-32023","volume":"70","author":"T Bernhardt","year":"2002","unstructured":"Bernhardt T, Seidler A, Fr\u00f6lich L. The effect of psychosocial factors on risk of dementia. Fortschr Neurol Psychiatr. 2002;70(6):283\u20138.","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"3","key":"361_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mrdd.20163","volume":"13","author":"WB Zigman","year":"2007","unstructured":"Zigman WB, Lott IT. Alzheimer\u2019s disease in Down syndrome: neurobiology and risk. Ment Retard Dev Disabil Res Rev. 2007;13(3):237\u201346.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"361_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1192\/bjp.180.5.405","volume":"180","author":"N Schupf","year":"2002","unstructured":"Schupf N, Sergievsky GH. Genetic and host factors for dementia in Down\u2019s syndrome. Br J Psychiatry. 2002;180:405\u201310.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"361_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2559.1988.tb02018.x","volume":"13","author":"DM Mann","year":"1988","unstructured":"Mann DM. Alzheimer\u2019s disease and Down\u2019s syndrome. Histopathology. 1988;13(2):125\u201337.","journal-title":"Histopathology"},{"key":"361_CR38","doi-asserted-by":"crossref","unstructured":"Bush A, Beail N. Risk factors for dementia in people with Down syndrome: issues in assessment and diagnosis. Am J Ment Retard. 2004;109(2):83\u201397.","DOI":"10.1352\/0895-8017(2004)109<83:RFFDIP>2.0.CO;2"},{"issue":"12","key":"361_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040920","volume":"10","author":"EL Zeilinger","year":"2020","unstructured":"Zeilinger EL, Komenda S, Zrnic I, Franken F, Woditschka K. Informant-based assessment instruments for dementia and their measurement properties in persons with intellectual disability: systematic review protocol. BMJ Open. 2020;10(12): e040920.","journal-title":"BMJ Open"},{"key":"361_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2017.08.024","volume":"114","author":"P Zis","year":"2018","unstructured":"Zis P, Strydom A. Clinical aspects and biomarkers of Alzheimer\u2019s disease in Down syndrome. Free Radical Biol Med. 2018;114:3\u20139.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"361_CR41","volume":"12","author":"F Lai","year":"2020","unstructured":"Lai F, Mhatre PG, Yang Y, Wang MC, Schupf N, Rosas HD. Sex differences in risk of Alzheimer\u2019s disease in adults with Down syndrome. Alzheimers Dement (Amst). 2020;12(1): e12084.","journal-title":"Alzheimers Dement (Amst)"},{"key":"361_CR42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1212\/WNL.50.4.991","volume":"50","author":"N Schupf","year":"1998","unstructured":"Schupf N, Kapell D, Nightingale B, Rodr\u00edguez \u00c1, Tycko B, Mayeux RP. Earlier onset of Alzheimer\u2019s disease in men with Down syndrome. Neurology. 1998;50:991\u20135.","journal-title":"Neurology"},{"key":"361_CR43","doi-asserted-by":"crossref","unstructured":"Lai F, Kammann E, Rebeck GW, Anderson A, Chen YF, Nixon R. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. Neurology. 1999;53:331\u20136.","DOI":"10.1212\/WNL.53.2.331"},{"issue":"1","key":"361_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2788.2001.00299.x","volume":"45","author":"V Temple","year":"2008","unstructured":"Temple V, Jozsvai E, Konstantareas MM, Hewitt TA. Alzheimer dementia in Down\u2019s syndrome: the relevance of cognitive ability. J Intellect Disabil Res. 2008;45(1):47\u201355.","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"361_CR45","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1017\/S1355617702813248","volume":"8","author":"Y Stern","year":"2002","unstructured":"Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8(3):448\u201360.","journal-title":"J Int Neuropsychol Soc"},{"issue":"3 Suppl 2","key":"361_CR46","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/00002093-200607001-00010","volume":"20","author":"Y Stern","year":"2006","unstructured":"Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20(3 Suppl 2):S69-74.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"361_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol. 2011;10(3):241\u201352.","journal-title":"Lancet Neurol"},{"issue":"8","key":"361_CR48","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jamaneurol.2021.1893","volume":"78","author":"A Bejanin","year":"2021","unstructured":"Bejanin A, Iulita MF, Vilaplana E, et al. Association of apolipoprotein E \u025b4 Allele with clinical and multimodal biomarker changes of Alzheimer disease in adults with Down syndrome. JAMA Neurol. 2021;78(8):937\u201347.","journal-title":"JAMA Neurol"},{"issue":"6","key":"361_CR49","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neurobiolaging.2006.12.013","volume":"29","author":"AMW Coppus","year":"2008","unstructured":"Coppus AMW, Evenhuis HM, Verberne GJ, et al. The impact of apolipoprotein E on dementia in persons with Down\u2019s syndrome. Neurobiol Aging. 2008;29(6):828\u201335.","journal-title":"Neurobiol Aging"},{"key":"361_CR50","doi-asserted-by":"crossref","unstructured":"van Gool WA, Evenhuis HM, van Duijn CM. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing. Ann Neurol. 1995;38(2):225\u201330.","DOI":"10.1002\/ana.410380215"},{"issue":"11","key":"361_CR51","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/gps.2039","volume":"23","author":"VP Prasher","year":"2008","unstructured":"Prasher VP, Sajith SG, Rees SD, et al. Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer\u2019s disease and mortality in persons with Down syndrome. Int J Geriatr Psychiatry. 2008;23(11):1134\u201340.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"361_CR52","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/jcm10091882","volume":"10","author":"SE Pape","year":"2021","unstructured":"Pape SE, Baksh RA, Startin C, Hamburg S, Hithersay R, Strydom A. The association between physical activity and CAMDEX-DS changes prior to the onset of Alzheimer\u2019s disease in Down syndrome. J Clin Med. 2021;10(9):1882.","journal-title":"J Clin Med"},{"issue":"1","key":"361_CR53","doi-asserted-by":"publisher","first-page":"16825","DOI":"10.1038\/s41598-017-17201-8","volume":"7","author":"M Parrini","year":"2017","unstructured":"Parrini M, Ghezzi D, Deidda G, et al. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome. Sci Rep. 2017;7(1):16825.","journal-title":"Sci Rep"},{"key":"361_CR54","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.expneurol.2012.11.022","volume":"240","author":"E Kida","year":"2013","unstructured":"Kida E, Rabe A, Walus M, Albertini G, Golabek AA. Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn. Exp Neurol. 2013;240:178\u201389.","journal-title":"Exp Neurol"},{"issue":"4","key":"361_CR55","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.neuroscience.2010.09.043","volume":"171","author":"MV Llorens-Mart\u00edn","year":"2010","unstructured":"Llorens-Mart\u00edn MV, Rueda N, Tejeda GS, Fl\u00f3rez J, Trejo JL, Mart\u00ednez-Cu\u00e9 C. Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome. Neuroscience. 2010;171(4):1228\u201340.","journal-title":"Neuroscience"},{"key":"361_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbr.2015.08.015","volume":"296","author":"M Walus","year":"2016","unstructured":"Walus M, Kida E, Rabe A, Albertini G, Golabek AA. Widespread cerebellar transcriptome changes in Ts65Dn Down syndrome mouse model after lifelong running. Behav Brain Res. 2016;296:35\u201346.","journal-title":"Behav Brain Res"},{"issue":"2","key":"361_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ng1095-177","volume":"11","author":"RH Reeves","year":"1995","unstructured":"Reeves RH, Irving NG, Moran TH, et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet. 1995;11(2):177\u201384.","journal-title":"Nat Genet"},{"key":"361_CR58","doi-asserted-by":"crossref","unstructured":"Contestabile A, Greco B, Ghezzi D, Tucci V, Benfenati F, Gasparini L. Lithium rescues synaptic plasticity and memory in Down syndrome mice. J Clin Invest. 2012;123(1):348\u201361.","DOI":"10.1172\/JCI64650"},{"issue":"7","key":"361_CR59","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/sj.npp.1301535","volume":"33","author":"A Costa","year":"2008","unstructured":"Costa A, Scott-McKean JJ, Stasko MR. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Neuropsychopharmacology. 2008;33(7):1624\u201332.","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"361_CR60","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","volume":"22","author":"A Duchon","year":"2011","unstructured":"Duchon A, Raveau M, Chevalier C, Nalesso V, Sharp AJ, Herault Y. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome. 2011;22(11):674\u201384.","journal-title":"Mamm Genome"},{"key":"361_CR61","first-page":"103","volume":"9","author":"KJ Gardiner","year":"2015","unstructured":"Gardiner KJ. Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. Drug Des Dev Ther. 2015;9:103.","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"361_CR62","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.dhjo.2018.02.003","volume":"11","author":"LT Ptomey","year":"2018","unstructured":"Ptomey LT, Szabo AN, Willis EA, et al. Changes in cognitive function after a 12-week exercise intervention in adults with Down syndrome. Disabil Health J. 2018;11(3):486\u201390.","journal-title":"Disabil Health J"},{"issue":"7","key":"361_CR63","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/jir.12163","volume":"59","author":"CC Chen","year":"2015","unstructured":"Chen CC, Ringenbach S, Crews D, Kulinna P, Amazeen EL. The association between a single bout of moderate physical activity and executive function in young adults with Down syndrome: a preliminary study. J Intellect Disabil Res. 2015;59(7):589\u201398.","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"361_CR64","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1352\/1934-9556-52.2.124","volume":"52","author":"SD Ringenbach","year":"2014","unstructured":"Ringenbach SD, Albert AR, Chen CC, Alberts JL. Acute bouts of assisted cycling improves cognitive and upper extremity movement functions in adolescents with Down syndrome. Intellect Dev Disabil. 2014;52(2):124\u201335.","journal-title":"Intellect Dev Disabil"},{"key":"361_CR65","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ridd.2015.08.003","volume":"45\u201346","author":"SD Holzapfel","year":"2015","unstructured":"Holzapfel SD, Ringenbach SDR, Mulvey GM, et al. Improvements in manual dexterity relate to improvements in cognitive planning after assisted cycling therapy (ACT) in adolescents with Down syndrome. Res Dev Disabil. 2015;45\u201346:261\u201370.","journal-title":"Res Dev Disabil"},{"issue":"6","key":"361_CR66","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/jir.12258","volume":"60","author":"CC Chen","year":"2016","unstructured":"Chen CC, Ringenbach S. Dose\u2013response relationship between intensity of exercise and cognitive performance in individuals with Down syndrome: a preliminary study. J Intellect Disabil Res. 2016;60(6):606\u201314.","journal-title":"J Intellect Disabil Res"},{"issue":"11","key":"361_CR67","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/jir.12275","volume":"60","author":"SD Ringenbach","year":"2016","unstructured":"Ringenbach SD, Holzapfel SD, Mulvey GM, Jimenez A, Benson A, Richter M. The effects of assisted cycling therapy (ACT) and voluntary cycling on reaction time and measures of executive function in adolescents with Down syndrome. J Intellect Disabil Res. 2016;60(11):1073\u201385.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"361_CR68","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/jir.12603","volume":"63","author":"C-C Chen","year":"2019","unstructured":"Chen C-C, Ringenbach SDR. The effect of acute exercise on the performance of verbal fluency in adolescents and young adults with Down syndrome: a pilot study. J Intellect Disabil Res. 2019;63(6):614\u201323.","journal-title":"J Intellect Disabil Res"},{"issue":"8","key":"361_CR69","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/20445911.2016.1205592","volume":"28","author":"SD Holzapfel","year":"2016","unstructured":"Holzapfel SD, Ringenbach SDR, Mulvey GM, Sandoval-Menendez AM, Birchfield N, Tahiliani SR. Differential effects of assisted cycling therapy on short-term and working memory of adolescents with Down syndrome. J Cogn Psychol. 2016;28(8):990\u20131003.","journal-title":"J Cogn Psychol"},{"key":"361_CR70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neurobiolaging.2021.07.016","volume":"107","author":"V Fleming","year":"2021","unstructured":"Fleming V, Piro-Gambetti B, Patrick A, et al. Physical activity and cognitive and imaging biomarkers of Alzheimer\u2019s disease in Down syndrome. Neurobiol Aging. 2021;107:118\u201327.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"361_CR71","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.ridd.2013.03.009","volume":"34","author":"CC Chen","year":"2013","unstructured":"Chen CC, Span\u00f2 G, Edgin JO. The impact of sleep disruption on executive function in Down syndrome. Res Dev Disabil. 2013;34(6):2033\u20139.","journal-title":"Res Dev Disabil"},{"issue":"4","key":"361_CR72","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/aje\/kwm116","volume":"166","author":"KJ Anstey","year":"2007","unstructured":"Anstey KJ, von Sanden C, Salim A, O\u2019Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166(4):367\u201378.","journal-title":"Am J Epidemiol"},{"key":"361_CR73","doi-asserted-by":"crossref","unstructured":"Durazzo TC, Mattsson N, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms. Alzheimers Dement. 2014;10(3 Suppl):S122\u201345.","DOI":"10.1016\/j.jalz.2014.04.009"},{"issue":"5","key":"361_CR74","first-page":"619","volume":"13","author":"K Wisniewski","year":"1978","unstructured":"Wisniewski K, Howe J, Williams DG, Wisniewski HM. Precocious aging and dementia in patients with Down\u2019s syndrome. Biol Psychiatry. 1978;13(5):619\u201327.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"361_CR75","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.410170310","volume":"17","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome. Ann Neurol. 1985;17(3):278\u201382.","journal-title":"Ann Neurol"},{"key":"361_CR76","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/412536","volume":"2012","author":"E Head","year":"2012","unstructured":"Head E, Silverman W, Patterson D, Lott I. Aging and Down syndrome. Curr Gerontol Geriatrics Res. 2012;2012: 412536.","journal-title":"Curr Gerontol Geriatrics Res"},{"key":"361_CR77","doi-asserted-by":"publisher","unstructured":"H\u00f6hne C, Messungen der regionalen Corpus-callosum-und Hippocampus-Atrophie bei nicht dementen Erwachsenen mit Down-Syndrom C. Hoehne lmu. 2007. https:\/\/doi.org\/10.5282\/edoc.7687.","DOI":"10.5282\/edoc.7687"},{"key":"361_CR78","doi-asserted-by":"crossref","unstructured":"Pearlson GD, Breiter SN, Aylward EH, et al. MRI brain changes in subjects with Down syndrome with and without dementia. Dev Med Child Neurol .1998;40(5):326\u201334.","DOI":"10.1111\/j.1469-8749.1998.tb15384.x"},{"issue":"Pt 2","key":"361_CR79","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1365-2788.2003.00445.x","volume":"47","author":"VP Prasher","year":"2003","unstructured":"Prasher VP, Cumella S, Natarajan K, Rolfe EB, Shah S, Haque MS. Magnetic resonance imaging, Down\u2019s syndrome and Alzheimer\u2019s disease: research and clinical implications. J Intellectual Disability Res. 2003;47(Pt 2):90\u2013100.","journal-title":"J Intellectual Disability Res"},{"key":"361_CR80","unstructured":"Ball M, Schapiro M, Rapoport SI. Neuropathological relationships between Down syndrome and senile dementia Alzheimer type. In: Epstein CJ, editor. The neurobiology of Down syndrome. New York: Raven; 1986. p. 45\u201358."},{"key":"361_CR81","doi-asserted-by":"crossref","unstructured":"Pujol J, Fenoll R, Ribas-Vidal N, et al. A longitudinal study of brain anatomy changes preceding dementia in Down syndrome. Neuroimage Clin. 2018;18:160\u20136.","DOI":"10.1016\/j.nicl.2018.01.024"},{"issue":"4667","key":"361_CR82","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.6474172","volume":"225","author":"BT Hyman","year":"1984","unstructured":"Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer\u2019s disease: cell-specific pathology isolates the hippocampal formation. Science. 1984;225(4667):1168\u201370.","journal-title":"Science"},{"issue":"6","key":"361_CR83","first-page":"909","volume":"17","author":"M Bobinski","year":"1996","unstructured":"Bobinski M, Wegiel J, Wisniewski HM, et al. Neurofibrillary pathology\u2014correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging. 1996;17(6):909\u201319.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"361_CR84","first-page":"76","volume":"7","author":"Z Nagy","year":"1996","unstructured":"Nagy Z, Jobst KA, Esiri MM, et al. Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer\u2019s disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. Dementia. 1996;7(2):76\u201381.","journal-title":"Dementia"},{"issue":"8","key":"361_CR85","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","volume":"46","author":"F Lai","year":"1989","unstructured":"Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46(8):849\u201353.","journal-title":"Arch Neurol"},{"issue":"6","key":"361_CR86","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/0197-4580(92)90096-G","volume":"13","author":"MB Schapiro","year":"1992","unstructured":"Schapiro MB, Haxby JV, Grady CL. Nature of mental retardation and dementia in Down syndrome: Study with PET, CT, and neuropsychology. Neurobiol Aging. 1992;13(6):723\u201334.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"361_CR87","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1097\/00001756-199705260-00009","volume":"8","author":"GE Alexander","year":"1997","unstructured":"Alexander GE, Saunders AM, Szczepanik J, et al. Relation of age and apolipoprotein E to cognitive function in Down syndrome adults. NeuroReport. 1997;8(8):1835\u201340.","journal-title":"Neuroreport"},{"issue":"Pt 5","key":"361_CR88","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1046\/j.1365-2788.2001.00379.x","volume":"45","author":"LD Nelson","year":"2001","unstructured":"Nelson LD, Orme D, Osann K, Lott IT. Neurological changes and emotional functioning in adults with Down syndrome. J Intellect Disabil Res. 2001;45(Pt 5):450\u20136.","journal-title":"J Intellect Disabil Res"},{"key":"361_CR89","doi-asserted-by":"crossref","unstructured":"Bobinski M, Leon MJd, Wegiel J, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience. 1999;95:721\u20135.","DOI":"10.1016\/S0306-4522(99)00476-5"},{"issue":"10","key":"361_CR90","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/archneur.1993.00540100061017","volume":"50","author":"H Yamauchi","year":"1993","unstructured":"Yamauchi H, Fukuyama H, Harada K, et al. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer\u2019s disease. Arch Neurol. 1993;50(10):1070\u20134.","journal-title":"Arch Neurol"},{"issue":"4","key":"361_CR91","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archneur.56.4.467","volume":"56","author":"SJ Teipel","year":"1999","unstructured":"Teipel SJ, Hampel H, Pietrini P, et al. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. Arch Neurol. 1999;56(4):467\u201373.","journal-title":"Arch Neurol"},{"issue":"5","key":"361_CR92","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1212\/WNL.51.5.1381","volume":"51","author":"SJ Teipel","year":"1998","unstructured":"Teipel SJ, Hampel H, Alexander GE, et al. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer\u2019s disease. Neurology. 1998;51(5):1381\u20135.","journal-title":"Neurology"},{"issue":"2","key":"361_CR93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/archneur.59.2.243","volume":"59","author":"SJ Teipel","year":"2002","unstructured":"Teipel SJ, Bayer W, Alexander GE, et al. Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol. 2002;59(2):243\u20138.","journal-title":"Arch Neurol"},{"key":"361_CR94","doi-asserted-by":"crossref","unstructured":"Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, M\u00f6ller HJ. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J Neural Transm (Vienna). 2002;109(5\u20136):837\u201355.","DOI":"10.1007\/s007020200069"},{"issue":"1\u20132","key":"361_CR95","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0006-8993(92)90178-C","volume":"598","author":"F Aboitiz","year":"1992","unstructured":"Aboitiz F, Scheibel AB, Fisher RS, Zaidel E. Fiber composition of the human corpus callosum. Brain Res. 1992;598(1\u20132):143\u201353.","journal-title":"Brain Res"},{"key":"361_CR96","first-page":"291","volume-title":"General organization of callosal connections in the cerebral cortex","author":"GM Innocenti","year":"1986","unstructured":"Innocenti GM. General organization of callosal connections in the cerebral cortex. Sensory-motor areas and aspects of cortical connectivity: Springer; 1986. p. 291\u2013353."},{"key":"361_CR97","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-6610-6","volume-title":"Cerebral Cortex","author":"EG Jones","year":"1984","unstructured":"Jones EG, Peters A. Cellular components of the cerebral cortex. In: Cerebral Cortex, Vol 1. US: Springer; 1984. https:\/\/books.google.de\/books?id=SxwrjwEACAAJ."},{"key":"361_CR98","doi-asserted-by":"crossref","unstructured":"Hof PR, Morrison JH, Cox K. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol. 1990;301(1):44\u201354.","DOI":"10.1002\/cne.903010105"},{"key":"361_CR99","doi-asserted-by":"crossref","unstructured":"Hof PR, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J Comparative Neurol. 1990;301(1):55\u201364.","DOI":"10.1002\/cne.903010106"},{"issue":"3","key":"361_CR100","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0014-4886(91)90096-U","volume":"111","author":"PR Hof","year":"1991","unstructured":"Hof PR, Morrison JH. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer\u2019s disease. Exp Neurol. 1991;111(3):293\u2013301.","journal-title":"Exp Neurol"},{"key":"361_CR101","first-page":"35","volume":"33","author":"S Weis","year":"1991","unstructured":"Weis S, Jellinger K, Wenger E. Morphometry of the corpus callosum in normal aging and Alzheimer\u2019s disease. J Neural Transm Suppl. 1991;33:35\u20138.","journal-title":"J Neural Transm Suppl"},{"issue":"4","key":"361_CR102","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0197-4580(94)90070-1","volume":"15","author":"A Biegon","year":"1994","unstructured":"Biegon A, Eberling JL, Richardson BC, et al. Human corpus callosum in aging and Alzheimer\u2019s disease: a magnetic resonance imaging study. Neurobiol Aging. 1994;15(4):393\u20137.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"361_CR103","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF00868519","volume":"243","author":"P Vermersch","year":"1996","unstructured":"Vermersch P, Roche J, Hamon M, et al. White matter magnetic resonance imaging hyperintensity in Alzheimer\u2019s disease: correlations with corpus callosum atrophy. J Neurol. 1996;243(3):231\u20134.","journal-title":"J Neurol"},{"issue":"2","key":"361_CR104","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0925-4927(97)00009-7","volume":"74","author":"IK Lyoo","year":"1997","unstructured":"Lyoo IK, Satlin A, Lee CK, Renshaw PF. Regional atrophy of the corpus callosum in subjects with Alzheimer\u2019s disease and multi-infarct dementia. Psychiatry Res. 1997;74(2):63\u201372.","journal-title":"Psychiatry Res"},{"key":"361_CR105","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-7091-7508-8_12","volume":"54","author":"J Pantel","year":"1998","unstructured":"Pantel J, Schroder J, Essig M, et al. Corpus callosum in Alzheimer\u2019s disease and vascular dementia\u2013a quantitative magnetic resonance study. J Neural Transm Suppl. 1998;54:129\u201336.","journal-title":"J Neural Transm Suppl"},{"issue":"5","key":"361_CR106","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jnnp.69.5.623","volume":"69","author":"H Yamauchi","year":"2000","unstructured":"Yamauchi H, Fukuyama H, Nagahama Y, et al. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2000;69(5):623\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"361_CR107","first-page":"400","volume":"101","author":"FE Visser","year":"1997","unstructured":"Visser FE, Aldenkamp AP, van Huffelen AC, Kuilman M, Overweg J, van Wijk J. Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. Am J Mental Retardation. 1997;101(4):400\u201312.","journal-title":"Am J Mental Retardation"},{"key":"361_CR108","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1192\/bjp.172.6.493","volume":"172","author":"AJ Holland","year":"1998","unstructured":"Holland AJ, Hon J, Huppert FA, Stevens F, Watson P. Population-based study of the prevalence and presentation of dementia in adults with Down\u2019s syndrome. Br J Psychiatry. 1998;172:493\u20138.","journal-title":"Br J Psychiatry"},{"issue":"6","key":"361_CR109","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1212\/WNL.44.6.1039","volume":"44","author":"JP Kesslak","year":"1994","unstructured":"Kesslak JP, Nagata SF, Lott I, Nalcioglu O. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down\u2019s syndrome. Neurology. 1994;44(6):1039\u201345.","journal-title":"Neurology"},{"key":"361_CR110","doi-asserted-by":"crossref","unstructured":"Raz N, Torres IJ, Briggs SD, et al. Selective neuroanatornic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology. 1995;45(2):356\u201366.","DOI":"10.1212\/WNL.45.2.356"},{"issue":"2","key":"361_CR111","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/REVNEURO.1989.2.2.101","volume":"2","author":"RC Pearson","year":"1989","unstructured":"Pearson RC, Powell TP. The neuroanatomy of Alzheimer\u2019s disease. Rev Neurosci. 1989;2(2):101\u201322.","journal-title":"Rev Neurosci"},{"issue":"1","key":"361_CR112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1212\/WNL.41.1.51","volume":"41","author":"JP Kesslak","year":"1991","unstructured":"Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer\u2019s disease. Neurology. 1991;41(1):51\u20134.","journal-title":"Neurology"},{"key":"361_CR113","doi-asserted-by":"crossref","unstructured":"Krasuski JS, Alexander GE, Horwitz B, Rapoport SI, Schapiro MB. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down\u2019s syndrome: implications for the prodromal phase of Alzheimer\u2019s disease. Am J Psychiatry. 2002;159(1):74\u201381.","DOI":"10.1176\/appi.ajp.159.1.74"},{"key":"361_CR114","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1073\/pnas.052587399","volume":"99","author":"RI Scahill","year":"2002","unstructured":"Scahill RI, Schott JM, Stevens J, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer\u2019s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA. 2002;99:4703\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"361_CR115","first-page":"929","volume":"15","author":"S Lehericy","year":"1994","unstructured":"Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. Am J Neuroradiol. 1994;15(5):929\u201337.","journal-title":"Am J Neuroradiol"},{"issue":"4","key":"361_CR116","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.92","volume":"49","author":"D Chan","year":"2001","unstructured":"Chan D, Fox NC, Scahill RI, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer\u2019s disease. Ann Neurol. 2001;49(4):433\u201342.","journal-title":"Ann Neurol"},{"issue":"5","key":"361_CR117","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0197-4580(01)00271-8","volume":"22","author":"BC Dickerson","year":"2001","unstructured":"Dickerson BC, Goncharova I, Sullivan M, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer\u2019s disease. Neurobiol Aging. 2001;22(5):747\u201354.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"361_CR118","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1212\/WNL.58.8.1188","volume":"58","author":"R Killiany","year":"2002","unstructured":"Killiany R, Hyman B, Gomez-Isla T, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 2002;58(8):1188\u201396.","journal-title":"Neurology"},{"key":"361_CR119","doi-asserted-by":"crossref","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(4):a006213-a.","DOI":"10.1101\/cshperspect.a006213"},{"key":"361_CR120","doi-asserted-by":"crossref","unstructured":"Delabar J, Blouin J, Rahmani Z, et al. Down syndrome: a model for the study of Alzheimer\u2019s disease and aging. Early markers in Parkinson\u2019s and Alzheimer\u2019s Diseases. Vienna: Springer; 1990. p. 165\u201379.","DOI":"10.1007\/978-3-7091-9098-2_17"},{"issue":"6","key":"361_CR121","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","volume":"11","author":"D Hartley","year":"2015","unstructured":"Hartley D, Blumenthal T, Carrillo M, et al. Down syndrome and Alzheimer\u2019s disease: common pathways, common goals. Alzheimers Dementia. 2015;11(6):700\u20139.","journal-title":"Alzheimers Dementia"},{"issue":"2","key":"361_CR122","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-170920","volume":"63","author":"AD Dekker","year":"2018","unstructured":"Dekker AD, Sacco S, Carfi A, et al. The behavioral and psychological symptoms of dementia in Down syndrome (BPSD-DS) scale: comprehensive assessment of psychopathology in Down syndrome. J Alzheimers Dis. 2018;63(2):797\u2013819.","journal-title":"J Alzheimers Dis"},{"key":"361_CR123","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cortex.2015.07.032","volume":"73","author":"AD Dekker","year":"2015","unstructured":"Dekker AD, Strydom A, Coppus AMW, et al. Behavioural and psychological symptoms of dementia in Down syndrome: early indicators of clinical Alzheimer\u2019s disease? Cortex. 2015;73:36\u201361.","journal-title":"Cortex"},{"issue":"1","key":"361_CR124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jar.12920","volume":"35","author":"MBG Wissing","year":"2022","unstructured":"Wissing MBG, Ulgiati AM, Hobbelen JSM, De Deyn PP, Waninge A, Dekker AD. The neglected puzzle of dementia in people with severe\/profound intellectual disabilities: a systematic literature review of observable symptoms. J Appl Res Intellect Disabil. 2022;35(1):24\u201345.","journal-title":"J Appl Res Intellect Disabil"},{"issue":"3","key":"361_CR125","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron. 2009;63(3):287\u2013303.","journal-title":"Neuron"},{"issue":"8","key":"361_CR126","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1073\/pnas.92.8.3586","volume":"92","author":"BT Hyman","year":"1995","unstructured":"Hyman BT, West HL, Rebeck GW, et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci. 1995;92(8):3586\u201390.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"361_CR127","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3233\/JAD-201209","volume":"80","author":"SI Shiekh","year":"2021","unstructured":"Shiekh SI, Cadogan SL, Lin L-Y, Mathur R, Smeeth L, Warren-Gash C. Ethnic differences in dementia risk: a systematic review and meta-analysis. J Alzheimers Dis. 2021;80(1):337\u201355.","journal-title":"J Alzheimers Dis"},{"key":"361_CR128","doi-asserted-by":"crossref","unstructured":"Burt DB, Aylward EH, Working Group for the Establishment of Criteria for the Diagnosis of Dementia in Individuals with Intellectual Disability. Test battery for the diagnosis of demntia in individuals with intellectual disability. J Intellect Disabil Res. 2000;44(2):175\u201380.","DOI":"10.1046\/j.1365-2788.2000.00264.x"},{"issue":"2","key":"361_CR129","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-2788.1997.tb00692.x","volume":"41","author":"EH Aylward","year":"1997","unstructured":"Aylward EH, Burt DB, Thorpe LU, Lai F, Dalton A. Diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res. 1997;41(2):152\u201364.","journal-title":"J Intellect Disabil Res"},{"issue":"5","key":"361_CR130","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ridd.2009.01.010","volume":"30","author":"RE Nieuwenhuis-Mark","year":"2009","unstructured":"Nieuwenhuis-Mark RE. Diagnosing Alzheimer\u2019s dementia in Down syndrome: problems and possible solutions. Res Dev Disabil. 2009;30(5):827\u201338.","journal-title":"Res Dev Disabil"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00361-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-022-00361-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00361-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T16:11:42Z","timestamp":1675613502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-022-00361-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s40120-022-00361-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202204.0022.v1","asserted-by":"object"}]},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}